Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SAAVHA is a private health technology company developing blockchain- and biometrics-enabled software for identity verification, consent management, contact updates, and data integrity across healthcare, pharma/biotech research, government, education, and enterprise settings. Its core offerings are aimed at reducing fraud, protecting privacy, improving patient and research-subject retention, and enabling secure interactions without repeated disclosure of personally identifiable information. In healthcare and life sciences, the company positions its technology for payer workflows, remote or telephone-based identity confirmation, anonymous treatment support, clinical research follow-up, recruitment, and auditability of study data. SAAVHA appears to be a commercial-stage software platform company rather than a therapeutic drug developer, with no disclosed drug pipeline or clinical assets. The company emerged from a 2016 blockchain-health hackathon effort in Nashville and remains a small, venture-backed private business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SAAVHA.